Franklin Resources Inc Point Biopharma Global Inc. Transaction History

Franklin Resources Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$6.67 - $9.71 $252,339 - $367,348	37,832 New	37,832 $252,000
Q1 2022 May 13, 2022	SELL	$5.46 - $8.13 $4.22 Million - $6.29 Million	-773,700 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$4.83 - $9.75 $1.09 Million - $2.21 Million	-226,300 Reduced 22.63%	773,700 $4.33 Million
Q3 2021 Nov 12, 2021	BUY	$7.42 - $11.26 $7.42 Million - $11.3 Million	1,000,000 New	1,000,000 $7.69 Million

20K

Ticker PNT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 104,025,000
Description
POINT Biopharma Global Inc., a radiopharmaceutical company, focuses on the development and commercialization of radioligands that fight cancer. Its lead product candidates include PNT2002, a prostate-specific membrane antigen (PSMA) targeted radioligand that is in Phase III trial for the treatment of metastatic castration-resistant prostate canc...

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

Stay updated on Franklin Resources Inc with notifications on news.